Scoop: Turing is considering a $100M cash offer for the drug that triggered a national scandal over drug pricing
Turing Pharmaceuticals has received a $100 million offer for the drug that triggered a national uproar over drug price gouging, Endpoints News has learned. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.